Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
聽說Tenax Therapeutics將頒發名爲'LEVOSIMENDAN以保留射血分數治療肺動脈高壓伴心力衰竭'的美國專利
Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
聽說Tenax Therapeutics將頒發名爲'LEVOSIMENDAN以保留射血分數治療肺動脈高壓伴心力衰竭'的美國專利
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。